Silence Therapeutics SLN
NASDAQ SLN
$10.71 -0.22 (-2.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Shares Outstanding (Entity) (2018 - 2026)

Updated

Silence Therapeutics' Shares Outstanding (Entity) was 47.25 million in the quarter ended Jun 30, 2026, unchanged from 47.23 million a year earlier and unchanged from the prior quarter.

Analysis

Silence Therapeutics (SLN) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Shares Outstanding (Entity) at Silence Therapeutics came in at 47.23 million, unchanged from the prior year.

  • Shares Outstanding (Entity) shows a five-year compound annual growth rate of 11.2% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Shares Outstanding (Entity) was 47.22 million in the year ended Dec 31, 2024 (+19.2%), 39.62 million in the year ended Dec 31, 2023 (+10.2%), 35.94 million in the year ended Dec 31, 2022 (+20.1%) and 29.93 million in the year ended Dec 31, 2021 (+7.8%).
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Shares Outstanding (Entity) in data going back to the quarter ended Dec 31, 2018.
  • Compared with a year earlier, Shares Outstanding (Entity) was higher in three of the last seven quarters, with growth averaging 3.1%.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.0% (the quarter ended Mar 31, 2026) to 20.1% (the quarter ended Dec 31, 2022).
  • Per Business Quant data, SLN's Shares Outstanding (Entity) in the three quarters before the quarter ended Jun 30, 2026 was 47.23 million (quarter ended Mar 31, 2026), 47.23 million (quarter ended Dec 31, 2025) and 47.23 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Silence Therapeutics 516.41 Mn 444.31 Mn - 47.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.25 Mn
Mar 31, 2026 47.23 Mn
Dec 31, 2025 47.23 Mn
Sep 30, 2025 47.23 Mn
Jun 30, 2025 47.23 Mn
Mar 31, 2025 47.23 Mn
Dec 31, 2024 47.22 Mn
Sep 30, 2024 47.21 Mn
Jun 30, 2024 46.80 Mn
Mar 31, 2024 46.58 Mn
Dec 31, 2023 39.62 Mn
Dec 31, 2022 35.94 Mn
Dec 31, 2021 29.93 Mn
Dec 31, 2020 27.77 Mn
Dec 31, 2019 26.12 Mn
Dec 31, 2018 23.69 Mn
API Access

Silence Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SLN&period=max&api_key=YOUR_API_KEY